Seagen Inc

A medial security in the Health Care that looks (login to see)

Yahoo! Profile

SGEN

Biotechnology
Weighting

Weak Growth

Lead | Lag

Medial

Options

Selling (1.01)

P/E Ratio

53.21

Free Cash Flow

Negative (-0.33)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY